1. F. Ducray, E. Criniere, A. Idbaih, K. Mokhtari, Y. Marie, S. Paris, S. Navarro, F. Laigle-Donadey, C. Dehais, J. Thillet, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. alpha-Internexin expression identifies 1p19q codeleted gliomas. Neurology, 72(2):156-61, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Brain Neoplasms/diagnosis/*genetics, Chromosomes, Human, Pair 1/*genetics, Chromosomes, Human, Pair 19/*genetics, DNA Mutational Analysis, Disease Progression, Gene Deletion, Genes, Genetic Predisposition to Disease/*genetics, Genetic Screening, Genotype, Glioma/diagnosis/*genetics, Humans, Intermediate Filament Proteins/*genetics, Mutation/genetics, Oligodendroglioma/diagnosis/genetics, Predictive Value of Tests, Prognosis.



2. S. Everhard, J. Tost, H. El Abdalaoui, E. Criniere, F. Busato, Y. Marie, I. G. Gut, M. Sanson, K. Mokhtari, F. Laigle-Donadey, K. Hoang-Xuan, J. Y. Delattre, and J. Thillet. Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas. Neuro Oncol, 11(4):348-56, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Brain Neoplasms/enzymology/*genetics/pathology, CpG Islands, *DNA Methylation, DNA Modification Methylases/*genetics/*metabolism, DNA Repair Enzymes/*genetics/*metabolism, *Gene Expression Regulation, Enzymologic, Genotype, Glioblastoma/enzymology/*genetics/pathology, Humans, Promoter Regions, Genetic/*genetics, Tumor Suppressor Proteins/*genetics/*metabolism.



3. A. Idbaih, J. Aimard, B. Boisselier, Y. Marie, S. Paris, E. Criniere, R. Carvalho Silva, F. Laigle-Donadey, A. Rousseau, K. Mokhtari, J. Thillet, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma. Neuropathol Appl Neurobiol, 35(2):208-13, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Age of Onset, Brain Neoplasms/chemistry/*genetics, DNA Mutational Analysis, Female, Gene Expression, Glioblastoma/chemistry/*genetics, Humans, Male, Mutation, Missense, Protein Structure, Quaternary, Protein Structure, Tertiary, Receptor, Epidermal Growth Factor/chemistry/*genetics, Sex Characteristics.



4. G. Kaloshi, R. Guillevin, N. Martin-Duverneuil, F. Laigle-Donadey, D. Psimaras, Y. Marie, K. Mokhtari, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. Gray matter involvement predicts chemosensitivity and prognosis in gliomatosis cerebri. Neurology, 73(6):445-9, 2009. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Aged, 80 and over, Antineoplastic Agents/pharmacology/therapeutic use, Cell Movement/physiology, Cerebral Cortex/drug effects/*pathology, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasms, Neuroepithelial/*diagnosis/*drug therapy/mortality/pathology, Neuroglia/pathology, Predictive Value of Tests, Prognosis, Retrospective Studies, Survival Rate, Treatment Outcome, Young Adult.



5. J. Pallud, L. Capelle, L. Taillandier, D. Fontaine, E. Mandonnet, R. Guillevin, L. Bauchet, P. Peruzzi, F. Laigle-Donadey, M. Kujas, J. Guyotat, M. H. Baron, K. Mokhtari, and H. Duffau. Prognostic significance of imaging contrast enhancement for WHO grade II gliomas. Neuro Oncol, 11(2):176-82, 2009. Note: Journal ArticleUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Brain Neoplasms/*diagnosis, Contrast Media/*diagnostic use, Female, Gadolinium DTPA/*diagnostic use, Glioma/*diagnosis, Headache Disorders/diagnosis, Humans, Image Enhancement, *Magnetic Resonance Imaging, Male, Middle Aged, Nervous System Diseases/diagnosis, Prognosis, Seizures/diagnosis, Survival Rate, Young Adult.



6. M. Sanson, Y. Marie, S. Paris, A. Idbaih, J. Laffaire, F. Ducray, S. El Hallani, B. Boisselier, K. Mokhtari, K. Hoang-Xuan, and J. Y. Delattre. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol, 27(25):4150-4, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited Statesofficial journal of the American Society of Clinical Oncology. [WWW] Keyword(s): Adolescent, Adult, Aged, Aged, 80 and over, Brain Neoplasms/enzymology/*genetics/mortality/pathology/therapy, Codon, DNA Methylation, DNA Modification Methylases/genetics, DNA Repair Enzymes/genetics, Disease-Free Survival, Female, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Glioma/enzymology/*genetics/mortality/pathology/therapy, Humans, Isocitrate Dehydrogenase/*genetics, Kaplan-Meiers Estimate, Male, Middle Aged, *Mutation, Neoplasm Staging, Promoter Regions, Genetic, Proportional Hazards Models, Risk Assessment, Time Factors, Treatment Outcome, Tumor Markers, Biological/*genetics, Tumor Suppressor Proteins/genetics, Young Adult.



7. S. Taillibert, L. A. Vincent, B. Granger, Y. Marie, C. Carpentier, R. Guillevin, A. Bellanger, K. Mokhtari, A. Rousseau, D. Psimaras, C. Dehais, M. Sierra del Rio, Y. Meng, F. Laigle-Donadey, K. Hoang-Xuan, M. Sanson, and J. Y. Delattre. Bevacizumab and irinotecan for recurrent oligodendroglial tumors. Neurology, 72(18):1601-6, 2009. Note: Journal ArticleUnited States. [WWW] Keyword(s): Adult, Aged, Angiogenesis Inhibitors/administration & dosage/adverse effects, Antibodies, Monoclonal/*administration & dosage/adverse effects, Antineoplastic Agents, Phytogenic/administration & dosage/adverse effects, Brain Neoplasms/*drug therapy/pathology/physiopathology, Camptothecin/administration & dosage/adverse effects/*analogs &, derivatives, Cerebral Hemorrhage/epidemiology, DNA Mutational Analysis, Female, Genetic Predisposition to Disease/genetics, Genetic Screening, Humans, Male, Middle Aged, Neoplasm Recurrence, Local/*drug therapy/prevention & control, Oligodendroglioma/*drug therapy/pathology/physiopathology, Patient Compliance, Retrospective Studies, Survival Rate, Treatment Outcome, Young Adult.



8. F. Ducray, A. Idbaih, A. de Reynies, I. Bieche, J. Thillet, K. Mokhtari, S. Lair, Y. Marie, S. Paris, M. Vidaud, K. Hoang-Xuan, O. Delattre, J. Y. Delattre, and M. Sanson. Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile. Mol Cancer, 7:41, 2008. Note: Journal ArticleEngland. [WWW]



9. A. Idbaih, B. Boisselier, Y. Marie, M. Sanson, S. El Hallani, E. Criniere, M. Fourtassi, S. Paris, C. Carpentier, A. Rousseau, K. Mokhtari, C. Combadiere, F. Laigle-Donadey, K. Hoang-Xuan, and J. Y. Delattre. Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors. Brain Res, 1198:16-20, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adolescent, Adult, Age Factors, Aged, Brain Neoplasms/*genetics/metabolism/physiopathology, Chromosomes, Human, Pair 1/genetics, DNA Mutational Analysis, Female, Genetic Predisposition to Disease/*genetics, Genetic Screening, Genotype, Humans, Male, Middle Aged, Oligodendroglioma/*genetics/metabolism/physiopathology, Phenotype, Polymorphism, Single Nucleotide/*genetics, Prognosis, Proto-Oncogene Proteins c-mdm2/*genetics, Retrospective Studies, Survival Rate, Tumor Suppressor Protein p53/*genetics.



10. A. Idbaih, R. Carvalho Silva, E. Criniere, Y. Marie, C. Carpentier, B. Boisselier, S. Taillibert, A. Rousseau, K. Mokhtari, F. Ducray, J. Thillet, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Genomic changes in progression of low-grade gliomas. J Neurooncol, 90(2):133-40, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adult, Chromosome Deletion, Chromosomes, Disease Progression, Female, Genome/*genetics, Glioma/*genetics/*metabolism, Humans, Male, Microsatellite Repeats, Middle Aged, Nucleic Acid Hybridization/methods.



11. A. Idbaih, E. Criniere, Y. Marie, A. Rousseau, K. Mokhtari, M. Kujas, Y. El Houfi, C. Carpentier, S. Paris, B. Boisselier, F. Laigle-Donadey, J. Thillet, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas. Neuro Oncol, 10(4):540-7, 2008. Note: Journal ArticleUnited States. [WWW]



12. A. Idbaih, Y. Marie, C. Lucchesi, G. Pierron, E. Manie, V. Raynal, V. Mosseri, K. Hoang-Xuan, M. Kujas, I. Brito, K. Mokhtari, M. Sanson, E. Barillot, A. Aurias, J. Y. Delattre, and O. Delattre. BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas. Int J Cancer, 122(8):1778-86, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Astrocytoma/genetics/pathology, Brain Neoplasms/classification/*genetics/*pathology, *Chromosome Deletion, Chromosomes, Artificial, Bacterial, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 10, Chromosomes, Human, Pair 19, Chromosomes, Human, Pair 7, Chromosomes, Human, Pair 9, Disease-Free Survival, Female, Glioma/classification/*genetics/*pathology, Humans, Loss of Heterozygosity, Male, Middle Aged, Multivariate Analysis, Nucleic Acid Hybridization, Oligodendroglioma/genetics/pathology, Oligonucleotides, Predictive Value of Tests, Prognosis, Proportional Hazards Models, Receptor, Epidermal Growth Factor/*genetics, Survival Analysis, World Health Organization.



13. G. Kaloshi, S. Everhard, F. Laigle-Donadey, Y. Marie, S. Navarro, K. Mokhtari, A. Idbaih, F. Ducray, J. Thillet, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri. Neurology, 70(8):590-5, 2008. Note: Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Antineoplastic Agents, Alkylating/*therapeutic use, Chromosome Mapping, *Chromosomes, Human, Pair 19, Cohort Studies, DNA Mutational Analysis, Dacarbazine/*analogs & derivatives/therapeutic use, Disease-Free Survival, Female, Genetic Markers/physiology, Humans, Male, Middle Aged, Neoplasms, Neuroepithelial/*drug therapy/*genetics, O(6)-Methylguanine-DNA Methyltransferase/*metabolism, Prognosis, Retrospective Studies, Tumor Markers, Biological.



14. E. Criniere, G. Kaloshi, F. Laigle-Donadey, J. Lejeune, N. Auger, A. Benouaich-Amiel, S. Everhard, K. Mokhtari, M. Polivka, J. Y. Delattre, K. Hoang-Xuan, J. Thillet, and M. Sanson. MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities. J Neurooncol, 83:173-179, 2007. Note: Journal article. [WWW]



15. A. Idbaih, B. Boisselier, M. Sanson, E. Criniere, S. Liva, Y. Marie, C. Carpentier, S. Paris, F. Laigle-Donadey, K. Mokhtari, M. Kujas, K. Hoang-Xuan, O. Delattre, and J. Y. Delattre. Tumor genomic profiling and TP53 germline mutation analysis of first-degree relative familial gliomas. Cancer Genet Cytogenet, 176(2):121-126, 2007. Note: Journal article. [WWW]



16. G. Kaloshi, A. Benouaich-Amiel, F. Diakite, S. Taillibert, J. Lejeune, F. Laigle-Donadey, M. A. Renard, W. Iraqi, A. Idbaih, S. Paris, L. Capelle, H. Duffau, P. Cornu, J. M. Simon, K. Mokhtari, M. Polivka, A. Omuro, A. Carpentier, M. Sanson, J. Y. Delattre, and K. Hoang-Xuan. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology, 68(21):1831-6, 2007. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Antineoplastic Agents, Alkylating/administration & dosage, Brain Neoplasms/*drug therapy/*genetics/physiopathology, *Chromosome Deletion, Chromosomes, Human, Pair 1/genetics, Chromosomes, Human, Pair 19/genetics, DNA Mutational Analysis, Dacarbazine/administration & dosage/*analogs & derivatives, Drug Resistance, Neoplasm/*genetics, Female, Gene Expression Regulation, Neoplastic/drug effects/genetics, Genetic Screening, Genotype, Glioma/*drug therapy/*genetics/physiopathology, Humans, Loss of Heterozygosity/genetics, Male, Middle Aged, Neoplasm Recurrence, Local/drug therapy/genetics, Retrospective Studies, Survival Rate, Treatment Outcome.



17. G. Kaloshi, K. Mokhtari, C. Carpentier, S. Taillibert, J. Lejeune, Y. Marie, J. Y. Delattre, R. Godbout, and M. Sanson. FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status. J Neurooncol, 84:215-8, 2007. Note: Journal article. [WWW]



18. F. Keime-Guibert, O. Chinot, L. Taillandier, S. Cartalat-Carel, M. Frenay, G. Kantor, J. S. Guillamo, E. Jadaud, P. Colin, P. Y. Bondiau, P. Menei, H. Loiseau, V. Bernier, J. Honnorat, M. Barrie, K. Mokhtari, J. J. Mazeron, A. Bissery, and J. Y. Delattre. Radiotherapy for glioblastoma in the elderly. N Engl J Med, 356(15):1527-35, 2007. Note: Association of French-Speaking Neuro-OncologistsComparative StudyJournal ArticleMulticenter StudyRandomized Controlled TrialResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Aged, Aged, 80 and over, Astrocytoma/mortality/radiotherapy/therapy, Brain Neoplasms/mortality/*radiotherapy/therapy, Cognition/radiation effects, Female, Glioblastoma/mortality/*radiotherapy/therapy, Humans, Male, Proportional Hazards Models, Quality of Life, Radiotherapy Dosage, Survival Analysis.



19. D. Ricard, G. Kaloshi, A. Amiel-Benouaich, J. Lejeune, Y. Marie, E. Mandonnet, M. Kujas, K. Mokhtari, S. Taillibert, F. Laigle-Donadey, A. F. Carpentier, A. Omuro, L. Capelle, H. Duffau, P. Cornu, R. Guillevin, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Dynamic history of low-grade gliomas before and after temozolomide treatment. Ann Neurol, 61(5):484-90, 2007. Note: Journal ArticleUnited States. [WWW]



20. S. Camilleri-Broet, E. Criniere, P. Broet, V. Delwail, K. Mokhtari, A. Moreau, M. Kujas, M. Raphael, W. Iraqi, C. Sautes-Fridman, P. Colombat, K. Hoang-Xuan, and A. Martin. A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood, 107(1):190-6, 2006. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Aged, 80 and over, Antigens, Neoplasm/analysis, B-Lymphocytes/immunology/*pathology, Central Nervous System Neoplasms/classification/mortality/*pathology, Female, Germinal Center/immunology/*pathology, Humans, Immunohistochemistry, *Lymphocyte Activation/immunology, Lymphoma, B-Cell/classification/mortality/*pathology, Male, Middle Aged, Phenotype, Prognosis, Survival Analysis.



21. S. Everhard, G. Kaloshi, E. Criniere, A. Benouaich-Amiel, J. Lejeune, Y. Marie, M. Sanson, M. Kujas, K. Mokhtari, K. Hoang-Xuan, J. Y. Delattre, and J. Thillet. MGMT methylation: a marker of response to temozolomide in low-grade gliomas. Ann Neurol, 60(6):740-3, 2006. Note: Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Antineoplastic Agents, Alkylating/pharmacology/therapeutic use, Brain Neoplasms/diagnosis/*drug therapy/genetics, DNA Methylation/*drug effects, DNA Mutational Analysis, Dacarbazine/*analogs & derivatives/pharmacology/therapeutic use, Disease Progression, Female, Genetic Markers/drug effects/genetics, Glioma/diagnosis/*drug therapy/genetics, Humans, Male, Middle Aged, Neoadjuvant Therapy, Predictive Value of Tests, Prognosis, Promoter Regions (Genetics)/*drug effects/genetics, Survival Rate, Tumor Markers, Biological/*genetics, Tumor Suppressor Protein p14ARF/*genetics.



22. C. Houillier, J. Lejeune, A. Benouaich-Amiel, F. Laigle-Donadey, E. Criniere, K. Mokhtari, J. Thillet, J. Y. Delattre, K. Hoang-Xuan, and M. Sanson. Prognostic impact of molecular markers in a series of 220 primary glioblastomas. Cancer, 106(10):2218-23, 2006. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Base Sequence, Brain Neoplasms/*genetics/*mortality/pathology, Disease Progression, Female, Gene Expression Regulation, Neoplastic, Genes, erbB-1/*genetics, Genetic Markers, Glioblastoma/*genetics/*mortality/pathology, Humans, Male, Middle Aged, Molecular Sequence Data, Multivariate Analysis, Neoplasm Staging, Polymerase Chain Reaction, Probability, Prognosis, Proportional Hazards Models, Proto-Oncogene Proteins c-mdm2/*genetics, Registries, Retrospective Studies, Risk Assessment, Sensitivity and Specificity, Survival Analysis.



23. F. Laigle-Donadey, E. Criniere, A. Benouaich, E. Lesueur, K. Mokhtari, K. Hoang-Xuan, and M. Sanson. Loss of 22q chromosome is related to glioma progression and loss of 10q. J Neurooncol, 76(3):265-8, 2006. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Brain Neoplasms/*genetics/mortality/pathology, Chromosomes, Human, Pair 10, *Chromosomes, Human, Pair 22, Disease Progression, Genetic Markers, Glioma/*genetics/mortality/pathology, Humans, *Loss of Heterozygosity, Microsatellite Repeats, Reverse Transcriptase Polymerase Chain Reaction, Survival Analysis.



24. A. M. Omuro, C. C. Leite, K. Mokhtari, and J. Y. Delattre. Pitfalls in the diagnosis of brain tumours. Lancet Neurol, 5(11):937-48, 2006. Note: Journal ArticleReviewEngland. [WWW] Keyword(s): Brain Diseases/diagnosis, Brain Neoplasms/classification/*diagnosis, Diagnosis, Differential, Diagnostic Imaging/*methods/*trends, Humans.



25. A. Idbaih, Y. Marie, G. Pierron, C. Brennetot, K. Hoang-Xuan, M. Kujas, K. Mokhtari, M. Sanson, J. Lejeune, A. Aurias, O. Delattre, and J. Y. Delattre. Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol, 58(3):483-7, 2005. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Brain Neoplasms/classification/*genetics, *Chromosome Deletion, *Chromosomes, Human, Pair 1, Female, Gene Expression Profiling, Glioma/classification/*genetics, Humans, Loss of Heterozygosity, Male, Middle Aged.



26. M. Kujas, J. Lejeune, A. Benouaich-Amiel, E. Criniere, F. Laigle-Donadey, Y. Marie, K. Mokhtari, M. Polivka, M. Bernier, F. Chretien, A. Couvelard, L. Capelle, H. Duffau, P. Cornu, P. Broet, J. Thillet, A. F. Carpentier, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas. Ann Neurol, 58(2):322-6, 2005. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Brain Neoplasms/*genetics/pathology, *Chromosome Deletion, *Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 19, Female, Glioma/*genetics/pathology, Humans, Immunohistochemistry/methods, *Loss of Heterozygosity, Male, Middle Aged, Molecular Biology/methods.



27. F. Laigle-Donadey, S. Taillibert, K. Mokhtari, J. Hildebrand, and J. Y. Delattre. Dural metastases. J Neurooncol, 75(1):57-61, 2005. Note: Journal ArticleReviewNetherlands. [WWW] Keyword(s): Dura Mater/*pathology, Hematoma, Subdural/diagnosis/mortality, Humans, Meningioma/diagnosis/mortality/*secondary.



28. K. Mokhtari, S. Paris, L. Aguirre-Cruz, N. Privat, E. Criniere, Y. Marie, J. J. Hauw, M. Kujas, D. Rowitch, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification. Neuropathol Appl Neurobiol, 31(1):62-9, 2005. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Basic Helix-Loop-Helix Transcription Factors, Brain Neoplasms/*classification/metabolism/pathology, Chromosomes, Human, Pair 1, Glial Fibrillary Acidic Protein/*metabolism, Glioma/*classification/metabolism/pathology, Humans, Immunohistochemistry, Loss of Heterozygosity, Nerve Tissue Proteins/*metabolism, Tumor Suppressor Protein p53/*metabolism.



29. L. Aguirre-Cruz, K. Mokhtari, K. Hoang-Xuan, Y. Marie, E. Criniere, S. Taillibert, M. Lopes, J. Y. Delattre, and M. Sanson. Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors. J Neurooncol, 67(3):265-71, 2004. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Astrocytes/metabolism, Basic Helix-Loop-Helix Transcription Factors, Brain Neoplasms/genetics/*metabolism/pathology, DNA Probes, DNA-Binding Proteins/genetics/*metabolism, Helix-Loop-Helix Motifs, Humans, In Situ Hybridization, Nerve Tissue Proteins/genetics/*metabolism, Neurons/metabolism, Oligodendroglia/metabolism.



30. B. Benyahia, S. Huguet, X. Decleves, K. Mokhtari, E. Criniere, J. F. Bernaudin, J. M. Scherrmann, and J. Y. Delattre. Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1. J Neurooncol, 66(1-2):65-70, 2004. Note: Journal ArticleNetherlands. [WWW] Keyword(s): Antineoplastic Agents, Phytogenic/*pharmacology, Brain Neoplasms/*metabolism/pathology/physiopathology, Cell Death/drug effects, Cell Line, Tumor, Dose-Response Relationship, Drug, Drug Resistance, Neoplasm/*drug effects, Drug Synergism, Etoposide/*pharmacology, Female, Glioma/*metabolism/pathology/physiopathology, Humans, Indomethacin/administration & dosage/*pharmacology, Male, Middle Aged, Osmolar Concentration, P-Glycoprotein/*metabolism, Vincristine/*pharmacology.



31. K. Hoang-Xuan, L. Capelle, M. Kujas, S. Taillibert, H. Duffau, J. Lejeune, M. Polivka, E. Criniere, Y. Marie, K. Mokhtari, A. F. Carpentier, F. Laigle, J. M. Simon, P. Cornu, P. Broet, M. Sanson, and J. Y. Delattre. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol, 22(15):3133-8, 2004. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited Statesofficial journal of the American Society of Clinical Oncology. [WWW] Keyword(s): Adult, Aged, Antineoplastic Agents, Alkylating/*therapeutic use, Astrocytoma/*drug therapy/*genetics, Brain Neoplasms/*drug therapy/*genetics, *Chromosome Deletion, Chromosomes, Human, Pair 1/*genetics, Dacarbazine/*analogs & derivatives/*therapeutic use, Female, Humans, Loss of Heterozygosity, Magnetic Resonance Imaging, Male, Middle Aged, Oligodendroglioma/*drug therapy/*genetics.



32. F. Laigle-Donadey, N. Martin-Duverneuil, J. Lejeune, E. Criniere, L. Capelle, H. Duffau, P. Cornu, P. Broet, M. Kujas, K. Mokhtari, A. Carpentier, M. Sanson, K. Hoang-Xuan, J. Thillet, and J. Y. Delattre. Correlations between molecular profile and radiologic pattern in oligodendroglial tumors. Neurology, 63(12):2360-2, 2004. Note: Comparative StudyJournal ArticleReviewUnited States. [WWW] Keyword(s): Adult, Aged, Brain Neoplasms/*genetics/pathology/*radiography, Cerebral Cortex/pathology/radiography, Chromosomes, Human, Pair 1/*genetics, Female, Humans, *Loss of Heterozygosity, Male, Microsatellite Repeats, Middle Aged, Oligodendroglioma/*genetics/pathology/*radiography, Retrospective Studies, Supratentorial Neoplasms/genetics/pathology/radiography.



33. P. Leuraud, E. Dezamis, L. Aguirre-Cruz, S. Taillibert, J. Lejeune, E. Robin, K. Mokhtari, A. L. Boch, P. Cornu, J. Y. Delattre, and M. Sanson. Prognostic value of allelic losses and telomerase activity in meningiomas. J Neurosurg, 100(2):303-9, 2004. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Aged, 80 and over, Chromosome Mapping, Disease Progression, Female, Humans, Loss of Heterozygosity/*genetics, Male, Meningeal Neoplasms/*genetics, Meningioma/*genetics, Middle Aged, Neoplasm Recurrence, Local/*genetics, Predictive Value of Tests, Prognosis, Telomerase/*genetics/physiology.



34. M. Sanson, S. Cartalat-Carel, S. Taillibert, M. Napolitano, L. Djafari, J. Cougnard, H. Gervais, F. Laigle, A. Carpentier, K. Mokhtari, L. Taillandier, O. Chinot, H. Duffau, J. Honnorat, K. Hoang-Xuan, and J. Y. Delattre. Initial chemotherapy in gliomatosis cerebri. Neurology, 63(2):270-5, 2004. Note: ANOCEF groupClinical TrialComparative StudyControlled Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Alkylating/adverse effects/*therapeutic use, Antineoplastic Combined Chemotherapy Protocols/administration &, dosage/adverse effects/*therapeutic use, Astrocytoma/drug therapy/radiotherapy, Brain Neoplasms/*drug therapy/pathology/radiotherapy, Combined Modality Therapy, Cranial Irradiation, Dacarbazine/adverse effects/*analogs & derivatives/*therapeutic use, Disease Progression, Disease-Free Survival, Drug Administration Schedule, Female, Hematologic Diseases/chemically induced, Humans, Karnofsky Performance Status, Lomustine/administration & dosage/adverse effects, Magnetic Resonance Imaging, Male, Middle Aged, Neoplasms, Neuroepithelial/*drug therapy/pathology/radiotherapy, Oligodendroglioma/drug therapy/radiotherapy, Procarbazine/administration & dosage/adverse effects, Survival Analysis, Treatment Outcome, Vincristine/administration & dosage/adverse effects.

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.

This document was translated from BibT_EX by bibtex2html